This article explores strategies for US pharmaceutical companies facing unsettled accounts in Singapore. It provides an overview of unsettled accounts, the challenges faced by US pharmaceutical companies, and the legal and regulatory considerations. The article then presents strategies to address unsettled accounts, including negotiating payment terms, collaborating with local partners,…